Revision in reference ranges of peripheral total leukocyte count and diffential leukocyte percentages based on a normal serum C-reactive protein level

Journal of the Formosan Medical Association

Volumn 106, Issue 8, 2007, Pages 608-616

  Huang, Zei Shung ^a   Lo, Shyh Chyi ^a   Tsay, Woei ^a   Hsu, Kwan Lih ^a   Chiang, Fu Tien ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Atherosclerosis; Leukocyte count; Reference range; Serum CRP level

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL COUNT; PROTEIN BLOOD LEVEL; REFERENCE VALUE;

EID: 34548472664     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(08)60017-0     Document Type: Article

References (49)

1. Kratz A, Sluss PM, Januzzi JL Jr, Lewandrowski KB. Appendices: Laboratory values of clinical importance. In: Kasper DL, Braunwald E, Fauci AS, et al, eds. Harrison's Principles of Internal Medicine, USA: McGraw-Hill, 2005: A-1 & A-2.
2. Elin RJ. Chapter 478: Reference intervals and laboratory values. In: Goldman L, Ausiello D, eds. Cecil's Textbook of Medicine. Philadelphia: Saunders, 2004:2502.
3. Geaghan SM. Appendix. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al, eds. Hematology: Basic Principles and Practice. Philadelphia: Churchill Livingstone, 2005:2733.
4. Appendix 1. In: Hoffbrand AV, Catovsky D, Tuddenham EGD, eds. Postgraduate Haematology. UK: Blackwell, 2005:1022.
5. Abramson N, Melton B. Leukocytosis: basics of clinical assessment. Am Fam Physician 2000;62:2053-60.
6. Gillum RF, Mussolino ME. White blood cell count and hypertension incidence. The NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol 1994;47:911-9.
7. Shen K, DeLano FA, Zweifach BW, Schmid-Schonbein GW. Circulating leukocyte counts, activation, and degranulation in Dahl hypertensive rats. Cir Res 1995;76:276-83.
8. Huang ZS, Chien KL, Yang CY, et al. Peripheral differential leukocyte counts in humans vary with hyperlipidemia, smoking, and body mass index. Lipids 2001;36:237-45.
9. Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors. Int J Epidemiol 1990;19:881-8.
10. Facchini F, Hollenbeck CB, Chen YN, et al. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 1992;232:267-72.
11. Pratley RE, Wilson C, Bogardus C. Relation of the white blood cell count to obesity and insulin resistance: effect of race and gender. Obesity Res 1995;3:563-71.
12. Nieto FJ, Szklo M, Folsom AR, et al. Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1992;136: 525-37.
13. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992;267:1253-6.
14. Ernst E. Haemorheological consequences of chronic cigarette smoking. J Cardiovasc Risk 1995;2:435-9.
15. Schwartz J, Weiss ST. Host and environmental factors influencing the peripheral blood leukocyte count. Am J Epidemiol 1991;134:1402-9.
16. Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996;16:499-503.
17. Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1993;125:855-63.
18. de Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: results over 18 years from the Normative aging study. J Clin Epidemiol 1990;43:153-7.
19. Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985;254:1932-7.
20. Huang ZS, Chien KL, Yang CY, et al. Peripheral differential leukocyte counts and subsequent mortality from all diseases, cancers, and cardiovascular diseases in Taiwanese. J Formos Med Assoc 2003;102:775-81.
21. Friedman GD, Tekawa I, Grimm RH, et al. The leukocyte count: correlates and relationship to coronary risk factors (the ARDIA study). Int J Epidemiol 1990;19:889-93.
22. Yarnell JWG, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83:836-44.
23. Belch JJF. The relationship between white blood cells and arterial disease. Curr Opin Lipidol 1994;5:440-6.
24. Prentice RL, Szatrowski TR Kato H, Mason MW. Leukocyte counts and cerebrovascular disease. J Chronic Dis 1982; 35:703-14.
25. Huang ZS, Jeng JS, Wang CH, et al. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis 2001;158:431-6.
26. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003;169:203-14.
27. Fukumori T, Ohta H, Okubo A, et al. New compact-type latex photometric immunoassay system for hemoglobin and three acute inflammation markers: neutrophil count, C-reactive protein, and anti-streptolysin O. J Clin Lab Anal 2002;16:95-102.
28. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol 2005;76(11 Suppl):2106-15.
29. Temelkova-Kurktschiev T, Siegert G, Bergmann S, et al. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metab Clin Exp 2002;51:743-9.
30. Lee CD, Folsom AR, Nieto FJ, et al. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 2001;154:758-64.
31. Gyrgolkay LA, Nikitin YP. Leukogram and white blood cells count in native people of Chukotka. Int J Circumpolar Health 2001;60:534-9.
32. Tefferi A, Hanson CA, Inwards DJ. How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clin Proc 2005;80:923-36.
33. Bain BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol 1996;49:664-6.
34. Hematological and nutritional biochemistry reference data for persons 6 months-74 years of age: United States, 1976-80. Vital Health Stat 11. December 1982;i-vi, 1-173.
35. Midha NK, Stratton CW. Laboratory tests in critical care. Crit Care Clin 1998;14:15-34.
36. Eberhard OK, Haubitz M, Brunkhorst FM, et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997;40:1250-6.
37. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology 1991;23:118-24.
38. Bell SA, Faust H, Schmid A, Meurer M. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol 1998; 113:327-32.
39. Szalai AJ. C-reactive protein (CRP) and autoimmune disease: facts and conjectures. Clin Dev Immunol 2004;11:221-6.
40. Szalai AJ, McCrory MA. Varied biologic functions of C-reactive protein: lessons learned from transgenic mice. Immunol Res 2002;26:279-87.
41. Rodriguez W, Mold C, Kataranovski M, et al. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum 2005;52:642-50.
42. Gronn M, Slordahl SH, Skrede S, Lie SO. C-reactive protein as an indicator of infection in the immunosuppressed child. Eur J Pediatr 1986;145:18-21.
43. Starke ID, de Beer FC, Donnelly JP, et al. Serum C-reactive protein levels in the management of infection in acute leukaemia. Eur J Cancer Clin Oncol 1984;20:319-25.
44. Cooper EH, Bunning R, Illingworth S, et al. Serial measurement of beta2 microglobulin, acute phase reactant proteins and the ESR in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia. Biomedicine 1978;29: 154-8.
45. Patton LL. Hematologic abnormalities among HIV-infected patients: associations of significance for dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88: 561-7.
46. Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997;81:449-70.
47. Koka PS, Reddy ST. Cytopenias in HIV infection: mechanisms and alleviation of hematopoietic inhibition. Curr HIV Res 2004;2:275-82.
48. Feldman JG, Goldwasser P, Holman S, et al. C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J Acquir Immune Defic Syndr 2003; 32:210-4.
49. Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 2000;96:2069-73.